These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 30423)

  • 21. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 23. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
    Knudtzon J
    Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
    Kraenzlin ME; Keller U; Keller A; Thélin A; Arnaud MJ; Stauffacher W
    J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenergic, insulin, and work interactions with adenosine's effects on in situ myocardial glucose uptake.
    Law WR; McLane MP
    Cardiovasc Res; 1996 May; 31(5):691-8. PubMed ID: 8763398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta adrenergic receptors in hyperglycemia and in induced hypoglycemia].
    Giovannelli G; Meschino S; Bayeli PF; Montagnani M
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(2):1169-87. PubMed ID: 4391685
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
    Walter RM; Dudl RJ; Palmer JP; Ensinck JW
    J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomic modulation of aminophylline influence on the electrophysiological effects of adenosine and adenosine triphosphate in the canine heart.
    Belhassen B; Ilia R; Greenspan AM; Horowitz LN
    Cardiovasc Res; 1987 Feb; 21(2):151-60. PubMed ID: 3664544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and coronary hemodynamic effects of Abbott (40557) and its interaction with aminophylline.
    Afonso S; Henderson RR; Folts JD; Rowe GG
    Basic Res Cardiol; 1975; 70(4):390-400. PubMed ID: 1191207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucocorticoid and aminophylline on glucose intolerance of adrenalectomized rats.
    De Santis RA; Garcia MG; Czerwinski C; Vo-van-Lan ; Gutman RA; Recant L; Penhos JC
    Endocrinology; 1973 Mar; 92(3):716-21. PubMed ID: 4701478
    [No Abstract]   [Full Text] [Related]  

  • 33. The failure of aminophylline to modulate glucagon release in man.
    Walter RM; Dudl RJ; Palmer JP; Ensinck JW
    Life Sci; 1982 Jun; 30(26):2277-84. PubMed ID: 6287147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of glucose tolerance and insulin response in partially depancreatized dogs.
    Sun AM; Coddling JA; Haist RE
    Diabetes; 1974 May; 23(5):424-32. PubMed ID: 4598091
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of aminophylline on hindlimb blood flow autoregulation during increased metabolism in dogs.
    Metting PJ; Weldy DL; Ronau TF; Britton SL
    J Appl Physiol (1985); 1986 Jun; 60(6):1857-64. PubMed ID: 3722055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine-induced insulin release in relation to the cyclic AMP system in man.
    Efendic S; Cerasi E; Luft R
    J Clin Endocrinol Metab; 1972 Jan; 34(1):67-72. PubMed ID: 4332668
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulatory and metabolic aspects of beta-adrenoceptor blockade.
    Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1393-400. PubMed ID: 2903649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of theophylline on the adipokinetic effect of glucagon in vivo.
    Grande F; Prigge WF; De Oya M
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):774-81. PubMed ID: 4645758
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of beta-adrenoceptor blockade on the cardiovascular and hyperglycaemic actions of diazoxide.
    Sponer G; Schelling P; Ganten D; Gross F
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):15-20. PubMed ID: 27727
    [No Abstract]   [Full Text] [Related]  

  • 40. [Potentiation of the effect of aminophylline on human myometrium and placental vessels' contractility by the action of adenosine].
    Krygicz J; Urban J
    Ginekol Pol; 1978 Jun; 49(6):481-5. PubMed ID: 689477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.